Yadan Wang 王雅丹

  • Citations Per Year
Learn More
In this study, we administered a modified schedule of weekly intravenous Bortezomib at 1.6 mg/m2 with dexamethasone (BD) and compared it to the standard 1.3 mg/m2 twice-weekly BD regimen in Chinese patients with newly diagnosed multiple myeloma (MM). We assessed the difference in efficacy, safety profile and survival between the once-weekly and twice-weekly(More)
  • 1